Corcept Therapeutics | Rörelsekostnader



Operating Expenses Ändra Datum
Acadia Pharmaceuticals USD 106.1M 112.66M 2024-12
Alaunos Therapeutics USD 1.15M 20K 2024-09
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Ardelyx USD 108M 12M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
BioMarin Pharmaceutical USD 585.91M 45.94M 2024-12
Bristol-Myers Squibb USD 11.55B 1.84B 2024-12
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Eli Lilly USD 8.38B 1.53B 2024-12
J&J USD 18.63B 500M 2024-12
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Merck USD 11.33B 1.4B 2024-12
Novartis USD 11.28B 1.73B 2024-12
Novartis USD 10.15B 579M 2024-12
Pacira USD 162.55M 145.55M 2024-12
Pfizer USD 18.17B 5.63B 2024-12
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12



Corcept Therapeutics Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Mar 2025.